Perception of risk from tobacco use is lower among cancer survivors who smoke

the ONA take:

A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit. In the study, cancer survivors who smoke reported fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who quit before or after their diagnosis.

The researchers report that patients with cancers strongly linked to smoking, such as lung and head and neck, had high initial quit rates; however, many relapse and begin smoking again. Quit rates are not high among patients with other cancers. Researchers feel they may not realize the connection between their cancer and smoking, or they did not receive advice or follow-up assistance in regard to smoking cessation.

The analysis also revealed that survivors who currently smoked reported more daily exposure to others who smoke. The researchers say this is a factor that needs to be considered when counseling patients about quitting smoking. They suggest that exposure to other smokers should be addressed when counseling patients with cancer to quit.

Smoking is a large contributor to cancer deaths in the United States.
A new study identified several factors that inhibit the efforts of cancer survivors who smoke to quit.
Cancer survivors who smoke report fewer negative opinions about smoking, have more barriers to quitting, and are around other smokers more often than survivors who had quit before or after their diagnosis, according to a new study appearing in Psycho-Oncology.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs